Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Psychiatria Danubina|November 9, 2010
Using non-steroidal anti-inflammatory drugs in the treatment of depressionAbigail Davis, Michael Gilhooley, Mark AgiusAnnals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 6, 2026
When the Eyes and Nose Collide: The Shared Pathways of RhinoconjunctivitisSophie Spicer, Abigail Davis, Anne K EllisPsychiatria Danubina|June 22, 2010
Suicide risk and choice of antidepressantAbigail Davis, Michael Gilhooley, Mark Agius, et al.Psychiatria Danubina|June 22, 2010
What do large scale studies of medication in schizophrenia add to our management strategies?Mark Agius, Abigail Davis, Michael Gilhooley, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 19, 2017
Development and validation of LC-MS/MS methods for the measurement of ribociclib, a CDK4/6 inhibitor, in mouse plasma and Ringer's solution and its application to a cerebral microdialysis studyAshish Kala, Yogesh T Patel, Abigail Davis, et al.Journal of Pharmaceutical and Biomedical Analysis|July 26, 2021
Development and validation of an LC-MS/MS method to quantify the bromodomain and extra-terminal (BET) inhibitor JQ1 in mouse plasma and brain microdialysate: Application to cerebral microdialysis studySreenath Nair, Abigail Davis, Olivia Campagne, et al.Molecules (Basel, Switzerland)|September 9, 2022
Development and Validation of a Sensitive and Specific LC-MS/MS Method for IWR-1-Endo, a Wnt Signaling Inhibitor: Application to a Cerebral Microdialysis StudySreenath Nair, Abigail Davis, Olivia Campagne, et al.Journal of Pharmaceutical and Biomedical Analysis|April 27, 2018
Development and validation of a sensitive LC MS/MS method for the measurement of the checkpoint kinase 1 inhibitor prexasertib and its application in a cerebral microdialysis studyBo Zhong, Anil Maharaj, Abigail Davis, et al.Cancer Chemotherapy and Pharmacology|May 13, 2019
CNS penetration of the CDK4/6 inhibitor ribociclib in non-tumor bearing mice and mice bearing pediatric brain tumorsYogesh T Patel, Abigail Davis, Suzanne J Baker, et al.Drug Metabolism and Pharmacokinetics|January 20, 2023
CNS penetration of methotrexate and its metabolite 7-hydroxymethotrexate in mice bearing orthotopic Group 3 medulloblastoma tumors and model-based simulations for childrenRachel S Perkins, Abigail Davis, Olivia Campagne, et al.Pageof 2